Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1951 3
1952 5
1953 1
1954 1
1955 4
1956 5
1957 4
1958 7
1959 3
1960 3
1961 12
1962 16
1963 27
1964 40
1965 25
1966 45
1967 36
1968 42
1969 41
1970 46
1971 52
1972 50
1973 38
1974 55
1975 44
1976 40
1977 77
1978 47
1979 49
1980 55
1981 74
1982 79
1983 68
1984 102
1985 105
1986 112
1987 128
1988 155
1989 125
1990 126
1991 119
1992 127
1993 156
1994 161
1995 148
1996 157
1997 170
1998 192
1999 192
2000 227
2001 211
2002 220
2003 248
2004 265
2005 276
2006 308
2007 286
2008 312
2009 323
2010 339
2011 397
2012 408
2013 416
2014 410
2015 386
2016 434
2017 423
2018 496
2019 463
2020 570
2021 599
2022 562
2023 559
2024 594
2025 661
2026 342

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,872 results

Results by year

Filters applied: . Clear all
Page 1
Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension.
Zimmer JA, Sims JR, Evans CD, Nery ESM, Wang H, Wessels AM, Tronchin G, Sato S, Raket LL, Andersen SW, Sapin C, Paget MA, Gueorguieva I, Ardayfio P, Khanna R, Brooks DA, Matthews BR, Mintun MA; Alzheimer’s Disease Neuroimaging Initiative. Zimmer JA, et al. Among authors: sato s. J Prev Alzheimers Dis. 2026 Feb;13(2):100446. doi: 10.1016/j.tjpad.2025.100446. Epub 2025 Dec 1. J Prev Alzheimers Dis. 2026. PMID: 41330788 Free PMC article. Clinical Trial.
A multimodal whole-slide foundation model for pathology.
Ding T, Wagner SJ, Song AH, Chen RJ, Lu MY, Zhang A, Vaidya AJ, Jaume G, Shaban M, Kim A, Williamson DFK, Robertson H, Chen B, Almagro-Pérez C, Doucet P, Sahai S, Chen C, Chen CS, Komura D, Kawabe A, Ochi M, Sato S, Yokose T, Miyagi Y, Ishikawa S, Gerber G, Peng T, Le LP, Mahmood F. Ding T, et al. Among authors: sato s. Nat Med. 2025 Nov;31(11):3749-3761. doi: 10.1038/s41591-025-03982-3. Epub 2025 Nov 5. Nat Med. 2025. PMID: 41193692 Free PMC article.
Recovery of infectious recombinant human norovirus using zebrafish embryos.
Kotaki T, Akieda Y, Chen Z, Onishi M, Komatsu S, Motooka D, Omori H, Tamiya S, Kanai Y, Minami S, Kawagishi T, Sakon N, Sato S, Ishitani T, Kobayashi T. Kotaki T, et al. Among authors: sato s. Proc Natl Acad Sci U S A. 2025 Dec 9;122(49):e2526726122. doi: 10.1073/pnas.2526726122. Epub 2025 Dec 4. Proc Natl Acad Sci U S A. 2025. PMID: 41343680 Free PMC article.
Global trend of food-induced anaphylaxis: Up to date.
Leung AS, Estrada-Reyes E, Goto K, Huang CH, Li JM, Nagarajan SA, Ranasinghe T, Sato S, Srisuwatchari W, Zepeda-Ortega B, Tham EH. Leung AS, et al. Among authors: sato s. Pediatr Allergy Immunol. 2025 Dec;36(12):e70246. doi: 10.1111/pai.70246. Pediatr Allergy Immunol. 2025. PMID: 41332221 Free PMC article. Review.
Therapeutic Strategies to Overcome Payload Resistance of Trastuzumab Deruxtecan in HER2-Positive Cancers.
Murase Y, Nanjo S, Arai S, Kondo S, Koba H, Liu Y, Fukuda K, Sato S, Kinoshita J, Inaki N, Ueda T, Nomura S, Tambo Y, Shimizu T, Horie M, Maeda D, Wong RW, Hosomichi K, Kobayashi T, Watanabe S, Yamamura K, Ohkura N, Abo M, Yano S. Murase Y, et al. Among authors: sato s. Cancer Sci. 2026 Apr;117(4):996-1009. doi: 10.1111/cas.70319. Epub 2026 Jan 17. Cancer Sci. 2026. PMID: 41548044 Free PMC article.
IL-13/IL-13Rα2 axis promotes proliferation of angiosarcoma cells.
Saito H, Chan JY, Omori I, Iwasawa O, Sugimori A, Nakajima H, Ichimura R, Sato S, Sumida H. Saito H, et al. Among authors: sato s. Sci Rep. 2025 Aug 25;15(1):31236. doi: 10.1038/s41598-025-15933-6. Sci Rep. 2025. PMID: 40855097 Free PMC article.
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer.
Zhang F, Nakayama I, Sakamoto N, Okemoto D, Jubashi A, Matsubara Y, Miyashita Y, Sato S, Ushiyama S, Kobayashi A, Okazaki U, Yamamoto K, Mishima S, Kotani D, Kawazoe A, Hashimoto T, Nakamura Y, Kuboki Y, Bando H, Kojima T, Yoshino T, Kuwata T, Shitara K. Zhang F, et al. Among authors: sato s. Ther Adv Med Oncol. 2025 Sep 20;17:17588359251369042. doi: 10.1177/17588359251369042. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 40985041 Free PMC article.
12,872 results
You have reached the last available page of results. Please see the User Guide for more information.